Rigel Pharmaceuticals (RIGL)

Add to Watchlists
Create an Alert
3.57 -0.15  -4.03% NASDAQ Dec 14, 20:00 Delayed 2m USD

Rigel Pharmaceuticals Shareholders Equity (Quarterly):

56.17M for Sept. 30, 2017
View 4,000+ financial data types
Browse...
View Full Chart

Rigel Pharmaceuticals Shareholders Equity (Quarterly) Chart

Export Data
Save Image
Print Image

Rigel Pharmaceuticals Historical Shareholders Equity (Quarterly) Data

View and export this data going back to 2000. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2017 56.17M
June 30, 2017 69.60M
March 31, 2017 84.08M
Dec. 31, 2016 55.03M
Sept. 30, 2016 65.94M
June 30, 2016 73.72M
March 31, 2016 75.45M
Dec. 31, 2015 91.38M
Sept. 30, 2015 96.41M
June 30, 2015 101.15M
March 31, 2015 112.15M
Dec. 31, 2014 128.25M
Sept. 30, 2014 146.85M
June 30, 2014 165.73M
March 31, 2014 188.33M
Dec. 31, 2013 208.25M
Sept. 30, 2013 223.40M
June 30, 2013 245.05M
March 31, 2013 265.31M
Dec. 31, 2012 289.10M
Sept. 30, 2012 174.80M
June 30, 2012 195.75M
March 31, 2012 216.58M
Dec. 31, 2011 236.15M
Sept. 30, 2011 257.96M
   
June 30, 2011 272.68M
March 31, 2011 149.31M
Dec. 31, 2010 166.13M
June 30, 2010 124.43M
March 31, 2010 92.78M
Dec. 31, 2009 109.87M
Sept. 30, 2009 130.31M
June 30, 2009 51.56M
March 31, 2009 76.97M
Dec. 31, 2008 104.16M
Sept. 30, 2008 130.74M
June 30, 2008 162.21M
March 31, 2008 189.61M
Dec. 31, 2007 82.18M
Sept. 30, 2007 94.32M
June 30, 2007 110.26M
March 31, 2007 72.82M
Dec. 31, 2006 87.23M
Sept. 30, 2006 99.43M
June 30, 2006 105.29M
March 31, 2006 103.78M
Dec. 31, 2005 108.59M
Sept. 30, 2005 103.88M
June 30, 2005 34.16M
March 31, 2005 44.79M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Shareholders' Equity

Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
Learn More

Advertisement

RIGL Shareholders Equity (Quarterly) Benchmarks

Benchmarks
Endocyte 101.75M
Catabasis Pharmaceuticals 15.66M
CytomX Therapeutics 45.48M

RIGL Shareholders Equity (Quarterly) Range, Past 5 Years

Minimum 55.03M Dec 2016
Maximum 289.10M Dec 2012
Average 137.07M

RIGL Shareholders Equity (Quarterly) Excel Add-In Codes

  • Metric Code: shareholders_equity
  • Latest data point: =YCP("RIGL", "shareholders_equity")
  • Last 5 data points: =YCS("RIGL", "shareholders_equity", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.